As feds fast-track psychedelic medicines, Colorado must keep faith with natural medicine program

By: Shannon Hughes

Outlets: Colorado Newsline

Published: May 11, 2026

Words: 780

Last Updated: 2 months, 2 weeks ago

Body Text Preview

Two signatures, 48 hours apart, just changed how psychedelic medicine arrives in America.

On April 18, President Donald Trump signed an executive order accelerating federal review of psychedelic drugs for serious mental illness. Within days, the FDA awarded three commissioner’s national priority vouchers — to Compass Pathways for psilocybin-assisted therapy in treatment-resistant depression, Usona Institute for psilocybin in major depressive disorder, and Otsuka for methylone (a relative of MDMA) in PTSD. These …

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.

About

FAQ

Email Us